• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    2/14/22 7:07:25 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials
    Get the next $SENS alert in real time by email
    SC 13G/A 1 tm226138d20_sc13ga.htm SCHEDULE 13G/A

     

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    (RULE 13d - 102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2

     

    (Amendment No. 5)*

     

    Senseonics Holdings, Inc.

    (Name of Issuer)

     

    Common Stock, $0.001 par value per share

    (Title of Class of Securities)

     

    81727U105

    (CUSIP Number)

     

    December 31, 2021

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    x       Rule 13d-1(b)

     

    ¨       Rule 13d-1(c)

     

    ¨       Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Page 1 of 5 Pages)

     

     

     

     

     

     

    Page 2 of 5

     

    CUSIP No. 81727U105

     

    1

    NAME OF REPORTING PERSON

     

    Gilder, Gagnon, Howe & Co. LLC

     

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)     ¨
        (b)     ¨
         
    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    0

     

    6

    SHARED VOTING POWER

     

    0

     

    7

    SOLE DISPOSITIVE POWER

     

    0

     

    8

    SHARED DISPOSITIVE POWER

     

    0

     

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

     

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES      ¨

     

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0%

     

    12

    TYPE OF REPORTING PERSON

     

    BD

     

           

     

     

     

     

    Page 3 of 5

     

    ITEM 1(a).Name of Issuer:

     

    Senseonics Holdings, Inc.

     

    Item 1(b).Address of Issuer's Principal Executive Offices:

     

    20451 Seneca Meadows Parkway

    Germantown, MD 20876

     

    Item 2(a).Name of Persons Filing:

     

    Gilder, Gagnon, Howe & Co. LLC

     

    Item 2(b).Address of Principal Business Office or, if None, Residence:

     

    475 10th Avenue

    New York, NY 10018

     

    Item 2(c).Citizenship:

     

    New York

     

    Item 2(d).Title of Class of Securities

     

    Common Stock

     

    Item 2(e).CUSIP Number:

     

    81727U105

     

    ITEM 3.IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) x Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
           
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ¨ Insurance company defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8).
           
      (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
           
      (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
           
      (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
           
      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
           
      (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);
           
      (j) ¨ A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J)
           
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

     

     

     

    Page 4 of 5

     

    Item 4.Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a)Amount beneficially owned: 0

     

    (b)Percent of class: 0%

     

    (c)Number of shares of Common Stock as to which such person has:

     

    (i)Sole power to vote or direct the vote: 0

     

    (ii)Shared power to vote or direct the vote: 0

     

    (iii)Sole power to dispose or direct the disposition: 0

     

    (iv)Shared power to dispose or direct the disposition: 0

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certification.

     

    By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.

     

     

     

     

    Page 5 of 5

     

    SIGNATURES

     

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

     

    Dated: February 14, 2022

     

     

      GILDER, GAGNON, HOWE & CO. LLC
         
         
      By: /s/ Laura Esposito
      Name: Laura Esposito
      Title: Chief Compliance Officer

     

     

    Get the next $SENS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SENS

    DatePrice TargetRatingAnalyst
    10/21/2025$9.00Hold
    Stifel
    8/27/2025$1.50Overweight
    Barclays
    7/15/2025$1.25Buy
    TD Cowen
    6/2/2025$1.10Buy
    H.C. Wainwright
    4/10/2025$2.00Outperform
    Mizuho
    7/19/2023$0.50Underperform
    Jefferies
    8/19/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SENS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Steven Edelman bought $65,500 worth of shares (10,000 units at $6.55), increasing direct ownership by 15% to 74,708 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/13/25 4:48:53 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Sullivan Frederick T. bought $31,840 worth of shares (5,415 units at $5.88), increasing direct ownership by 4% to 157,028 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/10/25 7:40:12 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Roeder Douglas A bought $87,450 worth of shares (15,000 units at $5.83), increasing direct ownership by 18% to 99,727 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/10/25 7:40:13 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Kaufman Francine covered exercise/tax liability with 4,605 shares, decreasing direct ownership by 4% to 123,948 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/18/25 7:00:12 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Sullivan Frederick T. covered exercise/tax liability with 6,402 shares, decreasing direct ownership by 4% to 150,626 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/18/25 7:00:17 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    GC & Corp. Development Advisor Horton Kenneth L covered exercise/tax liability with 5,997 shares, decreasing direct ownership by 4% to 144,434 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/18/25 7:00:08 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    SEC Filings

    View All

    SEC Form CERT filed by Senseonics Holdings Inc.

    CERT - Senseonics Holdings, Inc. (0001616543) (Filer)

    11/14/25 12:32:49 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form 8-A12B filed by Senseonics Holdings Inc.

    8-A12B - Senseonics Holdings, Inc. (0001616543) (Filer)

    11/14/25 7:01:18 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form 25 filed by Senseonics Holdings Inc.

    25 - Senseonics Holdings, Inc. (0001616543) (Filer)

    11/14/25 7:00:15 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference

    GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2025 Healthcare Conference, being held in New York, NY. 2025 Stifel Healthcare Conference Format: Fireside chat and one-on-one meetingsDate: Wednesday, November 12, 2025Time: 4:40 pm ETWebcast: Click here Interested parties may access a live and recorded webcast of the presentation on the "Investor Relations" section of the company's website at www.senseonics.com. About Se

    11/10/25 8:05:00 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Announces Transfer to Nasdaq Stock Exchange

    GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, has announced that as a decision in the best interest of the Company and its stockholders, it will transfer the listing of its common stock from the NYSE American to the Nasdaq Global Select Market ("Nasdaq"), effective after the market closes on November 14, 2025. The Company's stock is expected to begin trading on Nasdaq under the existing ticker symbol "SENS" on November 17, 2025. About Senseonics Senseonics Holdings, Inc. ("Sense

    11/10/25 8:00:00 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Reports Third Quarter Financial Results

    Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial responsibility from Ascensia Diabetes Care back to Senseonics GERMANTOWN, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights & Accomplishments: Generated revenue of $8.1 million in the third quarter of 2

    11/5/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel resumed coverage on Senseonics with a new price target

    Stifel resumed coverage of Senseonics with a rating of Hold and set a new price target of $9.00

    10/21/25 7:22:14 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Barclays initiated coverage on Senseonics with a new price target

    Barclays initiated coverage of Senseonics with a rating of Overweight and set a new price target of $1.50

    8/27/25 8:26:33 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    TD Cowen initiated coverage on Senseonics with a new price target

    TD Cowen initiated coverage of Senseonics with a rating of Buy and set a new price target of $1.25

    7/15/25 8:44:36 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Financials

    Live finance-specific insights

    View All

    Senseonics Holdings, Inc. Reports Third Quarter Financial Results

    Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial responsibility from Ascensia Diabetes Care back to Senseonics GERMANTOWN, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights & Accomplishments: Generated revenue of $8.1 million in the third quarter of 2

    11/5/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

    GERMANTOWN, Md., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its third quarter 2025 financial results after market close on Wednesday, November 5, 2025. Management will hold a conference call to review the Company's third quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by na

    10/22/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    $SENS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    2/13/24 5:13:59 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    7/7/23 4:35:55 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Senseonics Holdings Inc.

    SC 13G - Senseonics Holdings, Inc. (0001616543) (Subject)

    4/10/23 5:10:45 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials